EUCTR2008-000224-27-GB进行中（未招募）1 期
Systemic sclerosis associated interstitial lung disease: A longitudinal observational study assessing optimum treatment regimens. - Assessment of scleroderma lung disease
ewcastle upon Tyne NHS Foundation Trust0 个研究点目标入组 20 人开始时间: 2008年8月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Fulfill 1980 ACR preliminary classification criteria for SSc
- •Age >18 yrs
- •Presence of HRCT evidence of any ground glass opacification as a marker of alveolitis or other changes consistent with ILD
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Persistent microscopic haematuria
- •Persistent leucopenia (neutrophil count <1.5 x 10 9 /l) or thrombocytopenia (<140 x 10 9/l)
- •Pregnant or breast feeding or absence of contraception
- •Active chronic infection in lung or elsewhere
研究者
相似试验
招募中
不适用
Pulmonary manifestation in systemic sclerosis in Srinagarind HospitalHRCT findingSclerosisPulmonary manifestationSclerodermaTCTR20150422001MDResearch.kku300
招募中
不适用
Interstitial Lung Disease Trajectories in Patients With Systemic SclerosisInterstitial Lung DiseaseSystemic SclerosisNCT05345795Central Hospital, Nancy, France600
Unknown
不适用
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic SclerosisInterstitial Lung DiseasesSystemic SclerosisNCT01858259Gabriela Riemekasten1,372
终止
不适用
In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema PatientsPulmonary DiseasePulmonary EmphysemaNCT02556697University Hospital, Rouen9
招募中
不适用
Pulmonary involvement (interstitial lung disease of known etiology) in patients with Seropositive and ACPA positive Rheumatoid Arthritis (RA-ILD I and II)Early detection of lung involvement in RAM05.9M05.1J99.0Seropositive rheumatoid arthritis, unspecifiedRheumatoid lung diseaseDRKS00028871Boehringer Ingelheim Pharma GmbH & Co. KG200